Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20962661.
- Also identified by DOI 10.1097/GIM.0b013e3181f8baad and PMC identifier 3111046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Laboratory evaluation of patients with developmental delay/intellectual disability, congenital anomalies, and dysmorphic features has changed significantly in the last several years with the introduction of microarray technologies. Using these techniques, a patient's genome can be examined for gains or losses of genetic material too small to be detected by standard G-banded chromosome studies. This increased resolution of microarray technology over conventional cytogenetic analysis allows for identification of chromosomal imbalances with greater precision, accuracy, and technical sensitivity. A variety of array-based platforms are now available for use in clinical practice, and utilization strategies are evolving. Thus, a review of the utility and limitations of these techniques and recommendations regarding present and future application in the clinical setting are presented in this study.
Medical subject headings
- Chromosome Aberrations
- Chromosome Disorders
- Genetics, Medical
- Oligonucleotide Array Sequence Analysis